NeoGenomics, Inc (NEO) Q1 2025 Earnings Call Transcript

NeoGenomics, Inc (NASDAQ:NEO) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET

Company Participants

Kendra Sweeney - Vice President, Investor Relations and ESG
Tony Zook - Chief Executive Officer
Warren Stone - President and Chief Operating Officer
Andrew Lukowiak - Chief Innovation Officer
Jeffrey Sherman - Chief Financial Officer
Kareem Saad - Head, Strategy and Transformation
Ali Olivo - Executive Vice President, General Counsel & Business Development
Dr. Nate Montgomery - Vice President, Medical Services

Conference Call Participants

Andrew Brackman - William Blair
Dan Brennan - TD Cowen
Tejas Savant - Morgan Stanley
Mike Matson - Needham & Company
Matthew Sykes - Goldman Sachs
David Westenberg - Piper Sandler
Mason Carrico - Stephens
Andrew Cooper - Raymond James
Mark Massaro - BTIG, LLC
Jack Slevin - Jefferies
Puneet Souda - SVB Leerink

Operator

Greetings and welcome to the NeoGenomics First Quarter 2025 Conference Call. At this time, all participants are in a listen-only mode and a question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded.

I will now turn the conference over to your host, Kendra Sweeney, VP of Investor Relations. Ma'am you may begin.

Kendra Sweeney

Thank you, Holly. Good morning, everyone, and welcome to the NeoGenomics first quarter 2025 financial results call.

With me today to discuss the results are Tony Zook, Chief Executive Officer; Jeff Sherman, Chief Financial Officer; Warren Stone, President and Chief Operating Officer; and Andrew Lukowiak, Chief Innovation Officer. Additional members of the management team are available for Q&A, including Kareem Saad, Head of Strategy and Transformation; Ali Olivo, General Counsel and Head of Business Development; and Dr. Nate Montgomery, VP of Clinical Services.

This call is being simultaneously webcast, and we'll be referring to a slide presentation that has been posted to the Investors tab